LRBa0505/1
KP:kjf
2019 - 2020 LEGISLATURE
SENATE AMENDMENT 1,
TO SENATE BILL 300
September 16, 2019 - Offered by Senators Cowles and Miller.
SB300-SA1,1,11 At the locations indicated, amend the bill as follows:
SB300-SA1,1,3 21. Page 2, line 3: after “s. 146.81 (1)," insert “who have a specific focus on the
3diagnosis and treatment of infectious diseases,".
SB300-SA1,1,4 42. Page 2, line 12: delete “Two" and substitute “Three".
SB300-SA1,1,5 53. Page 2, line 21: after that line insert:
SB300-SA1,1,9 6“12. One technical director, or the equivalent, of a clinical microbiology
7laboratory, including, but not limited to, a person who is board certified by the
8American Board of Medical Microbiology to direct a medical and public health
9microbiology laboratory, appointed by the governor.
SB300-SA1,1,1010 13. One pharmacist, appointed by the governor.”.
SB300-SA1,2,3 114. Page 3, line 9: delete the material beginning with “people" and ending with
12“disease" on line 10 and substitute “patients about the increased potential of
13receiving a false negative test in the early stages of a tick-borne disease and the

1potential for a false positive test, along with recommendations to educate providers
2on how to interpret these tests, when testing is appropriate, and how to communicate
3test results to patients”.
Loading...
Loading...